Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-015780
Filing Date
2025-05-09
Accepted
2025-05-09 16:11:28
Documents
62
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q allr20250128_10q.htm   iXBRL 10-Q 775677
2 EXHIBIT 31.1 ex_771744.htm EX-31.1 12538
3 EXHIBIT 31.2 ex_771745.htm EX-31.2 12546
4 EXHIBIT 32.1 ex_771746.htm EX-32.1 6835
  Complete submission text file 0001437749-25-015780.txt   4316102

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA allr-20250331.xsd EX-101.SCH 42566
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE allr-20250331_cal.xml EX-101.CAL 31386
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE allr-20250331_def.xml EX-101.DEF 282654
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE allr-20250331_lab.xml EX-101.LAB 254682
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allr-20250331_pre.xml EX-101.PRE 310695
65 EXTRACTED XBRL INSTANCE DOCUMENT allr20250128_10q_htm.xml XML 564804
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41160 | Film No.: 25930531
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)